Table I.
Primary tumor status | |||||||
---|---|---|---|---|---|---|---|
Estrogen receptor | Progesterone receptor | ||||||
Variable | All patients | Positive | Negative | P-value | Positive | Negative | P-value |
Patients (n) | 70 | 48 | 22 | 38 | 32 | ||
Age (mean ± SD) | 54.5±15.5 | 55.8±15.5 | 51.8±15.6 | 0.320 | 53.6±17.3 | 55.6±13.3 | 0.603 |
Menopausal status (at original diagnosis) | |||||||
Premenopausal | 32 | 23 | 9 | 0.585 | 21 | 11 | 0.081 |
Postmenopausal | 38 | 25 | 13 | 17 | 21 | ||
Pathological type | |||||||
Invasive ductal carcinoma | 61 | 41 | 20 | 0.213 | 32 | 29 | 0.398 |
Invasive lobular carcinoma | 2 | 2 | 0 | 2 | 0 | ||
Invasive micropapillary carcinoma | 3 | 3 | 0 | 2 | 1 | ||
Medullary carcinoma | 2 | 0 | 1 | 0 | 1 | ||
Spindle cell carcinoma | 1 | 0 | 1 | 0 | 1 | ||
Ductal carcinoma in situ | 1 | 1 | 0 | 1 | 0 | ||
Surgical procedure | |||||||
Mastectomy | 54 | 39 | 15 | 0.227 | 30 | 24 | 0.695 |
Partial resection | 16 | 9 | 7 | 8 | 8 | ||
Histological grade | |||||||
1 | 8 | 6 | 2 | 0.001 | 5 | 3 | 0.314 |
2 | 35 | 30 | 5 | 22 | 13 | ||
3 | 18 | 10 | 8 | 8 | 10 | ||
Unknown | 9 | 2 | 7 | 3 | 6 | ||
TNM stage | |||||||
Tis | 1 | 1 | 0 | 0.801 | 1 | 0 | 0.568 |
T1 | 21 | 12 | 9 | 10 | 11 | ||
T2 | 33 | 24 | 9 | 20 | 13 | ||
T3 | 7 | 5 | 2 | 2 | 5 | ||
T4 | 5 | 4 | 1 | 3 | 2 | ||
Unknown | 3 | 2 | 1 | 2 | 1 | ||
N0 | 29 | 16 | 13 | 0.198 | 15 | 14 | 0.673 |
N1 | 34 | 25 | 9 | 19 | 15 | ||
N2 | 3 | 3 | 0 | 1 | 2 | ||
N3 | 2 | 2 | 0 | 1 | 1 | ||
Unknown | 2 | 2 | 0 | 2 | 0 | ||
Stage | |||||||
0 | 1 | 1 | 0 | 0.803 | 1 | 0 | 0.818 |
I | 14 | 17 | 7 | 7 | 7 | ||
II | 39 | 27 | 12 | 22 | 17 | ||
III | 13 | 11 | 2 | 6 | 7 | ||
Unknown | 3 | 2 | 1 | 2 | 1 |
SD, standard deviation.